These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11689832)

  • 21. Future societal issues in industrial biotechnology.
    Schuurbiers D; Osseweijer P; Kinderlerer J
    Biotechnol J; 2007 Sep; 2(9):1112-20. PubMed ID: 17639531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biotechnology patenting policy in the European Union--as exemplified by the development in Germany.
    Schrell A; Bauser H; Brunner H
    Adv Biochem Eng Biotechnol; 2007; 107():13-39. PubMed ID: 17522818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. European Commission rethinks biotech patents.
    Mitchell P
    Nat Biotechnol; 2002 Dec; 20(12):1175-6. PubMed ID: 12454654
    [No Abstract]   [Full Text] [Related]  

  • 24. EU biotech crop regulations and environmental risk: a case of the emperor's new clothes?
    Morris SH
    Trends Biotechnol; 2007 Jan; 25(1):2-6. PubMed ID: 17113665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biotech patenting matures.
    Lawrence S
    Nat Biotechnol; 2004 Oct; 22(10):1202. PubMed ID: 15470446
    [No Abstract]   [Full Text] [Related]  

  • 26. Private biotech 2004--the numbers.
    Hodgson J
    Nat Biotechnol; 2006 Jun; 24(6):635-41. PubMed ID: 16763589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biotech patenting slows in 2004.
    Lawrence S
    Nat Biotechnol; 2005 Oct; 23(10):1198. PubMed ID: 16211048
    [No Abstract]   [Full Text] [Related]  

  • 28. EC prepares strategic vision for biotechnology.
    Mitchell P
    Nat Biotechnol; 2002 Feb; 20(2):107-8. PubMed ID: 11821842
    [No Abstract]   [Full Text] [Related]  

  • 29. EC convenes crisis talks on European biotech sector.
    Jones D
    Nat Biotechnol; 2010 Feb; 28(2):110-1. PubMed ID: 20139930
    [No Abstract]   [Full Text] [Related]  

  • 30. Ambitious French biotech plan faces EU hurdle.
    Hodgson J
    Nat Biotechnol; 2003 Feb; 21(2):113-4. PubMed ID: 12560821
    [No Abstract]   [Full Text] [Related]  

  • 31. Meeting report: Symbiosis in Barcelona.
    Janssens B
    Biotechnol J; 2008 Jan; 3(1):23-7. PubMed ID: 18200494
    [No Abstract]   [Full Text] [Related]  

  • 32. Lessons for the nascent regenerative medicine industry from the biotech sector.
    Mason C; Dunnill P
    Regen Med; 2007 Sep; 2(5):753-6. PubMed ID: 17907927
    [No Abstract]   [Full Text] [Related]  

  • 33. State of biotech sector--2005.
    Lawrence S
    Nat Biotechnol; 2006 Jun; 24(6):603. PubMed ID: 16763577
    [No Abstract]   [Full Text] [Related]  

  • 34. 2007--a banner year for biotech.
    Lawrence S
    Nat Biotechnol; 2008 Feb; 26(2):150. PubMed ID: 18259162
    [No Abstract]   [Full Text] [Related]  

  • 35. Finding the substance behind the smoke: who is using biotechnology?
    Arunde A; Rose A
    Nat Biotechnol; 1998 Jul; 16(7):596-7. PubMed ID: 9661168
    [No Abstract]   [Full Text] [Related]  

  • 36. Product patents on human DNA sequences: an obstacle for implementing the EU Biotech Directive?
    Straus J
    Adv Genet; 2003; 50():65-78; discussion 507-10. PubMed ID: 14714686
    [No Abstract]   [Full Text] [Related]  

  • 37. Overcoming the challenges in the pharma/biotech industry.
    Graul AI; Prous JR
    Drug News Perspect; 2007; 20(1):57-68. PubMed ID: 17332900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Could bank loans solve Europe's biotech financing slump?
    Mitchell P
    Nat Biotechnol; 2005 Dec; 23(12):1459-60. PubMed ID: 16333276
    [No Abstract]   [Full Text] [Related]  

  • 39. Public biotechnology 2005--the numbers.
    Lähteenmäki R; Lawrence S
    Nat Biotechnol; 2006 Jun; 24(6):625-34. PubMed ID: 16763588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Navigating the European biotechnology association labyrinth: A commentary on the role of biotechnology associations, selecting the most appropriate ones, and why now is the time to join.
    Suojanen C
    N Biotechnol; 2010 May; 27(2):95-9. PubMed ID: 20211280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.